We produced a three dimensional (3D) bone tumor model (BTM) to study the interactions between healthy and tumor cells in a tumor tissue microenvironment, migration of the tumor cells and the efficacy of an anticancer drug, Doxorubicin, for personalized medicine applications.
Introduction
Cancer is a challenging health issue since the clinical success rate is very low. Presence of various cancer types, occurrence at different sites in the body and metastasis to other tissue or organs make the treatment difficult. The tumor may be benign or malignant. Cells of benign cancers do not spread to other tissues; meanwhile, malignant cells can migrate and metastasize. Most of the deaths are due to metastases occurring by migration of cancer cells via vascular or lymphatic system. Vascular or lymphatic system invasion happens when cancer cells break into blood vessels or lymph channels.
In case of bone, benign tumors do not metastasize but damage the bone structure and lower the mechanical strength.(1) One of the most prevalent primary malignant bone tumor is osteosarcoma (OS) and is primarily observed in children and young adults. (2) The survival rate in 5 years is 75% for bone cancers that do not spread from the primary site (3), but for the metastatic case general survival rate is 40% and in poor responders to chemotherapy the survival rate is lower, 20%. (3, 4) . In order to develop an effective therapy, a model system that closely mimics the tumor of the patient would be very valuable, especially in selecting drugs and dose regimens for that specific patient, in other words, for personalized therapy. (5) We also need tissue models which mimic the complex organization of the natural tissue the extracellular matrix (ECM) and the microenvironment of the cancer cells in the tumor area in order to understand the underlying mechanisms in cancer occurrence and to develop rational approaches for diagnosis and therapy. In the last five decades, mainly two-dimensional (2D) monolayer tissue cultures were used to simulate the cancer cell microenvironment and study cancer.(6) These 2D systems were simple, easy to construct and convenient to study cell behavior (viability, topography, expressed proteins, etc.). However, these 2D systems have higher oxygen, glucose and nutrient concentrations, and therefore, can poorly mimic the natural tumor microenvironments, (7) . It is also reported that the gene expression, topology, and biochemistry of the cells change in 2D cultures. (8) In addition, in 2D monolayer cultures the drugs tested show their toxic effects on the cells far more rapidly than in the natural 3D environment of the cancer tissue. (9) In the absence of interactions with the surrounding stroma as it is in the 2D environment, cells growing adherently lose their polarity which also alters several cell responses, such as apoptosis. All these reasons mentioned above led the researchers to make incorrect conclusions as in the case in most biologically targeted therapies which perform well in the lab but not in the clinics.(10) As a result, 3D organotypic models which better mimic the properties of the tumor tissue have become the preferred model types. Some researchers developed 3D models involving spheroids formed by spontaneous aggregation of the cells on agarose,(11) on poly(2hydroxyethylmethacrylate) (pHEMA) coated plates, (12) or on ultralow attachment culture 5 plates. (13) There are also matrix-based 3D tumor models. Ewing's sarcoma cells cultured on electrospun poly(ε-caprolactone) (PCL) mats was shown to mimic human tumors in terms of growth and expression levels of therapeutically targeted genes present in crucial signaling pathways. (14) Models constructed using osteosarcoma cells grown on silk fibroin scaffolds were capable of expressing specific surface markers (HIF-1a and bFGF) at levels close to that of xenograft tumors. (15) U2OS cell line (osteosarcoma) cultured in 3D collagen matrices activated 'Phosphatide Inositol-3 Kinase (PI3K) pathway' which is a critical intracellular signaling cascade influencing cell growth, migration, protein expression, and survival. (16) Even though these models attempted to mimic the 3D tumors, the healthy bone microenvironment that has critical importance in the tumor initiation and progression were not taken into consideration. In one study, the importance of tumor microenvironment was shown in a model of human bone cancer (Ewing's sarcoma, ES) where tumor cell spheroids were cultured in a bone tissue environment consisting of human mesenchymal stem cells in decellularized bone matrix. Their results demonstrated that cancer cells re-expressed focal adhesion and cancer-related genes that are normally highly expressed in tumors but they lost this property in monolayer cultures and gained angiogenic capacity that favor tumor initiation and progression.(17) They have taken their 3D construct one step further by developing a model containing both osteoclasts and osteoblasts within 3D mineralized bone matrix to mimic the in vivo bone osteolysis associated with the Ewing's sarcoma to understand the mechanisms underlying tumor progression and also for the development of new therapeutics. Culturing of ES cell spheroids in the bone microenvironment led to a decrease in bone density, connectivity, and matrix deposition. Additionally, a therapeutic reagent which have demonstrated efficacy in ES treatment, prevented bone resorption mediated by osteoclasts in the tumor model. (18) This model appeared suitable to understand the biology and genetic origin of tumor and underlying reasons of tumor progression. However, choice of the appropriate drug for personalized therapy and discovery of new agents in the treatment of bone cancer require reproducible models unlike the decellularized bone matrix-based models that are not obtained in the same composition for each test. It is important to develop biomimetic tumor models that involve the primary components required for the precise mimicking of in vivo conditions that are not exceedingly complex and, therefore will not lead to complex data analysis. (19) The main hypothesis of this study was that a bone tumor model could be constructed with a rigid bone-like exterior carrying healthy cells and a softer tumor tissue-like core carrying cancerous cells. In order to reflect the complex structure of bone, three biomaterials were selected; poly(lactic acid-co-glycolic acid) (PLGA) and β-tricalcium phosphate (β-TCP) as the organic and inorganic components of the healthy exterior region, and collagen as the tumorous core of 6 the model. To be able to closely mimic the complex structural and mechanical properties of bone, these biomaterials were used since they represent both the bone mineral and the softer tumor tissue better than any new polymer family.
One of our main aims was to mimic the interaction between healthy and tumor bone cells as in their natural microenvironment. Bone tumor model was constructed with well established biomaterials and with a naturally mimicking design to study the migration of healthy bone cells and tumor cells and interactions between them.
The 3D bone tumor model (BTM) developed in this study has two tissue engineered components; one mimics the tumor tissue and the other, the healthy bone environment surrounding the tumor.
A cylindrical collagen sponge was seeded with human osteosarcoma cells (Saos-2) and used as the tumor tissue mimic. PLGA sponge containing β-TCP (PLGA/TCP) was seeded with both human fetal osteoblastic cells (hFOB) and human umbilical vein endothelial cells (HUVECs) and constituted the healthy bone mimic. The collagen-based tumor mimic was inserted into a cavity at the center of the cylindrical shaped healthy bone mimic to form the complete bone tumor model (BTM). The interaction, communication, and migration of the cells in and between the two compartments of the BTM model were investigated. Then, the model was used to study the efficacy of an anticancer drug, Doxorubicin, in treating cancer in the tumor mimic.
One of the future applications of this model would be to employ it for personalized cancer therapy, especially in the determination of the effective drug types and doses using cancerous cells of the patient. Collagen type I was isolated from Sprague-Dawley rat tails as described by earlier studies. (20, 21) For the isolation steps, briefly, tendons from rat tails were dissolved in cold acetic acid (0.5 ᴍ), filtered, dialyzed against phosphate buffer, and centrifuged. The collagen pellet was dissolved in acetic acid (0.15 ᴍ), precipitated with NaCl solution (5% w.v -1 ), dialysis and centrifugation steps were repeated. Collagen precipitate was sterilized in ethanol (70%), frozen at -80 °C and lyophilized. In order to prepare the sponges, collagen solution (1.5 % w.v -1 in 0.5 ᴍ acetic acid) was placed in the Teflon mold ( Figure S1C) , frozen at -20 °C and lyophilized. They ( Figure   S1D ) were then dehydrothermally crosslinked by heating at 140 °C in a vacuum oven. (20, 22) Both sponges were characterized before cell seeding. Then the optimized ones were seeded with the required cells and brought together to form BTM.
Materials and Methods

Preparation of Sponges and 3D Bone Tumor
3D Bone Tumor Model
The PLGA/TCP and collagen sponges were seeded with the required cells and cultured, and then the cell seeded collagen sponge was inserted in its cavity to form the complete BTM ( Figure   S1E ).
Characterization of PLGA/TCP and Collagen Sponges
Contact Angle Measurement
The water contact angle of the sponges was measured using a contact angle goniometer (One Attention, Biolin Scientific, Finland). Distilled water (7 µL) was placed at 5 different locations on the sponges and contact angles were measured by processing the images using the software of the system.
Degradation
Degradation tests of PLGA/TCP sponges were conducted by incubating in sterile phosphate buffer saline (PBS) (0.01 M, pH 7.4) containing sodium azide (0.5 mg.mL -1 ) at 37 °C. Enzymatic degradation of uncrosslinked and DHT-crosslinked collagen sponges were studied in PBS (1)
where w0 and w1 are the dry weights of the samples at time zero and at various time points.
Compressive Mechanical Test
Compression test was performed on the PLGA/TCP and collagen sponges using universal test equipment (Shimadzu AGS-X, Japan, 5 kN load cell) with a compression rate of 0.5 mm.min -1 . 8
Scanning Electron Microscopy (SEM)
The samples were placed on carbon tapes (Electron Microscopy Sciences, USA) attached to SEM stubs, and coated with Au-Pd. Micrographs were obtained at 10-20 kV with SEM (QUANTA 400F Field Emission SEM, Netherland) at the METU Central Laboratory.
MicroCT Analysis
The samples were scanned with microcomputed tomography (microCT) (Bruker microCT, SkyScan 1172, Belgium). PLGA/TCP sponges were scanned with application of 100 kV and 100 mA power with Al 0.5 mm filter and collagen sponges by using 35 kV and 21 mA power.
Reconstruction was applied with standard software NRecon. Porosity was determined with CTAn software (CTAn, Bruker microCT). Calcium phosphate deposition on the hFOB/HUVEC seeded PLGA/TCP and cell free (control) scaffolds were determined by X-ray absorption spectra using the µCT. Control scaffolds without cells were also cultured in the growth medium for 21 days 34°C in the CO2 incubator. incubator. Saos-2 cells were seeded on collagen scaffolds (1x10 5 cells scaffold -1 ) and incubated at 37 °C in a CO2 incubator. Growth media was refreshed every other day (Figure 1A, B ). The absorbance value was converted to cell number by using percent reduction values and a calibration curve.
Alkaline Phosphatase (ALP) Activity
SensoLyte pNPP Alkaline Phosphatase Assay Kit was used to determine ALP production by hFOB cells on the PLGA/TCP scaffold. Briefly, samples were washed with component B, lysis buffer was added, frozen and thawed three times at -80 °C and 37 °C. Sonication (50 W, 20 s) was applied and contents were centrifuged (2000 rpm, 10 min). The supernatant (50 µL), ALP dilution buffer (50 µL) and Component A (50 µL) were added in to each well in 96 well plates, incubated for 1 h at 37 °C and then 50 µL stop solution was transferred to each well. Absorbances were measured at 405 nm by a plate reader. ALP concentration was calculated by using the calibration curve.
Immunocytochemistry
The cells present on the scaffolds were fixed by treating them with paraformaldehyde solution (4%) for 15 min at RT. Then, treated with Triton-X-100 solution (1%) for 5 min and incubated in 1% BSA solution at 37 °C to block nonspecific binding. Samples were stained by incubating in Alexa Fluor 532-Phalloidin for 1 h at 37 °C and DRAQ5 for 15 min at RT. Cell seeded samples were also sectioned with cryomicrotome into 20-30 μm thick slices, and transferred to Polysine™ Microscope Adhesion Slides. Sections were also incubated in Triton X-100, blocked in the 1% BSA solution, stained with Alexa Fluor 488 tagged anti-human CD31, Alexa Fluor 532-Phalloidin, and DRAQ5. These samples were examined with a confocal laser scanning microscope (CLSM) (Zeiss LSM 800, Germany).
Scanning Electron Microscopy (SEM)
Cell seeded scaffolds were washed twice with PIPES (piperazine-N,N'-bis(ethanesulfonic acid)) buffer, fixed by immersing the samples in paraformaldehyde (4% w.v -1 ) for 5 min and then lyophilized. Samples were coated with gold-palladium (Au-Pd) under vacuum and examined with SEM (FEI Quanta 200F, USA).
Construction of the Bone Tumor Model (BTM)
hFOB/HUVEC cells were co-cultured on PLGA/TCP scaffolds (as the healthy bone mimic) and
Saos-2 cells were cultured on collagen scaffolds (as the tumor mimic) for 2 days. Then, collagen scaffolds were placed in the central cavity of the PLGA/TCP scaffold, and cultured in EGM-2:DMEM/F12: McCoy's 5A (1:1:1) medium for 21 days (Figure 1C ). 
Statistical Analysis
All quantitative data in this study were expressed as mean ± standard deviations with n≥3 unless otherwise stated. Statistical analysis was performed with GraphPad Prism6 program. Differences between group means were analyzed with Student's T-test when the data were normally distributed. Comparisons of groups with one independent variable were performed with Oneway ANOVA with Tukey's posthoc test, to determine significant differences. When there were two independent variables, Two-way ANOVA was used. All values are represented as the mean ± standard deviation. Differences of p < 0.05 were considered significant.
Results and Discussion
We prepared a 3D-BTM which mimics the bone tumor together with health microenvironment around the tumor. Each compartment of the BTM examined separately to optimize the preparation conditions and then combined to form the final tissue model. Healthy and tumor parts were prepared from PLGA/TCP and collagen. PLGA/β-TCP scaffolds were used in many studies and demonstrated good cell-material interaction and osteoconductivity,(23) enhancement in the bone regeneration of critical bone defects, (24) better guidance in the culture of osteoblasts (25) and improvement in biological activity, such as calcium deposition. respectively. Results prove that existing of higher porogen content (NaCl in our case) had higher porosity in accordance with the literature. (28, 29) These results were also supported by SEM and microCT images (Figure 2A, B) . SEM also showed that treatment of the samples with O2 plasma removed the 'skin layer' that generally forms on the surfaces during lyophilization and blocks the openings of the pores (Figure 2C).(30,31) . (Figure 2D) . It is reported that anchoragedependent mammalian cells favor moderately hydrophilic surfaces. (32) (33) (34) We also have shown that cells do not prefer highly hydrophilic nor hydrophobic surfaces to attach. (35, 36) Thus the surfaces we obtained were not optimal but they were more suitable for cell seeding than the pristine PLGA/TCP form. Degradation studies showed that the scaffolds are very stable and lost only about 2% of their weight in 7 weeks incubation in PBS (Figure 2E) . (Figure 2F) . Similar results were also reported by He et al. for six cylindrical PLLA sponges with different NaCl content. They also reported that higher NaCl particle content led to a higher porosity and lower mechanical strength. (28) It is known that high porosity and pore interconnectivity are essential for cell migration and proliferation, as well as for proper nutrient exchange in the culture medium. The best scaffolds would be those with high and interconnected porosity, and high mechanical strength. Since the difference between mechanical strengths of the two scaffolds tested was not very high, the sponge with higher porosity, PLGA:TCP:NaCl (4:1:40), was selected. 
Characterization of Collagen Sponges
Porous collagen sponges prepared by lyophilization were examined with SEM and microCT.
Horizontal and longitudinal cross sections of these sponges were very similar without any significant difference (Figure 3A) . All sections had high porosity and interconnectivity which is required for efficient transport of nutrients and waste. (38) Porosities of the sponges were determined from both SEM and µCT data as 96.7% and 86% for PLGA:TCP:NaCl (4:1:40) and collagen sponges, respectively (Figure 3B, C) . The average diameters of the pores were measured by using ImageJ (NIH, USA) as 199±52 µm for PLGA:TCP:NaCl (4:1:40) and 50-150 μm for collagen scaffolds.
In bone tissue engineering, scaffolds are usually produced with pore sizes similar to that of trabecular bone (20-1500 μm). (38) It was also reported that pores in the range 160-270 μm support rapid and extensive angiogenesis within a scaffold. (39) The pore size of our PLGA:TCP constructs (199±52 μm) which were used to grow hFOB and HUVEC cells is in the range of the ideal pore size of the bone matrix. On the other hand, the osteoblasts were shown to populate more in smaller pores (40 μm) when they were grown in scaffolds with different pore sizes;
larger pore sizes (100 μm) facilitated cell migration. Also, the minimum porosity necessary for In the enzymatic stability tests, collagenase is used and it breaks the peptide bonds of collagen and cause destruction of extracellular matrix.(41) After 2 h incubation in collagenase solution, the weight loss for UXL-CS (70.5% ± 2.5) was higher than DHT-CS (58.3% ± 11.8). When we extended the treatment from 2 h to 4 h, UXL-CS completely disintegrated while DHT-CS lost a large fraction (73.8% ± 8.6) of its initial weight (Figure 3E) . A higher degree of stability (and therefore degradation) of DHT-CS was expected due to the crosslinking treatment.
Compressive elastic modulus of UXL-CS and DHT-CS were 111±18 kPa and 140±46 kPa as measured from the initial slopes of stress-strain curves. This shows that crosslinking enhanced the mechanical strength of the sponges in addition to increasing its stability (Figure 3F) .
Based on these results, DHT-CS was selected as the matrix to culture Saos2 cells and to serve as the tumor mimic. 
Properties of Tumor and Healthy Bone Mimics
Cell Proliferation and ALP Activity
Alamar Blue assay was performed on hFOB/HUVEC cells (1:1) seeded on the PLGA/TCP scaffold to study the cell proliferation (Figure 4A) . Cell seeding density was 2x10 5 cells and on Alamar Blue assay was also performed for Saos-2 cells seeded on the collagen scaffold ( Figure   4B ). Cell seeding density was half of that of the hFOB/HUVEC (1x10 5 ). Rate of proliferation of Saos-2 on TCPS was higher than on the collagen as was on the PLGA/TCP scaffold. In this case, however, the cell number increase on TCPS continued for 3 weeks but on collagen, the rate of cell number increase and the cell number itself were lower than on TCPS. ALP activity of hFOB on PLGA/TCP scaffold was determined on Days 1 and 7 (Figure 4C) . It increased during the 7 day incubation; however, ALP activity on the scaffold was about 3 times lower than the control. Since the cell numbers were not the same on different scaffolds the ALP values were normalized by dividing the results with the cell numbers. The normalized ALP activity on Day 7 was significantly (about 2-fold) higher (Figure 4D) showing that the cells on the sponges could produce significant amounts of ALP.
Microscopy and MicroCT Results
Nuclei and cytoskeletons of the cells were stained to study cell morphology, intercellular interaction, and cell-material interactions using CLSM and SEM. From Day 7 onwards, the cells spread over the surface and covered it completely (Figure 5A) . They showed filamentous extensions (filopodia) indicating interaction with the surface (Figure 5B) . Anti-human CD31
immunostaining of HUVECs on PLGA/TCP scaffolds (Figure 5C) showed expression of CD31.
Since this protein is excreted in high levels by early and mature endothelial cells, it is used to
show the presence of HUVECs on the specimen (42) . The CD31 staining in our samples proves the presence of the HUVECs which were seeded on the scaffolds. Staining of actin and nuclei also shows that both HUVECs and hFOBs exist on the section, which were also seeded on the scaffolds. Calcium phosphate (CaP) crystals produced by cells in addition to the TCP particles introduced during scaffold production are observed as white spots on the microCT images ( Figure 5D ). However, it is not possible to distinguish those produced by the cells and those were introduced during scaffold production from each other. The peaks on the X-ray absorption spectra of hFOB/HUVEC seeded PLGA/TCP scaffolds were also higher than the cell-free scaffolds (Figure 5D, right) and are most probably due to the calcium phosphate deposition by cells. The CLSM results of Saos-2 cells on the collagen tumor mimic are shown in Figure 5E -H. The cells started to spread, fill the pores of the collagen sponge, and interact with each other as the incubation time increased (Figure 5E ). On Days 14 and 21, the coverage is more extensive and the cells appear to be organized in the form of a layer. These increases were also indicated by the Alamar blue assay of the Saos-2 cells ( Figure 4B) . Here, the cell number did not increase further possibly because of the confluence of the cells. Cells interact with the surface with their filopodia (Figure 5F) . Meanwhile, it is also seen that the cells had migrated and attached to the walls of the pores at the core of the sponge (Figure 5G) . MicroCT analysis shows calcium phosphate forming capacities of the cells (Figure   5H ).
Cell presence, proliferation and secretion of calcium phosphate affected the porosity of the collagen sponges as they did with the PLGA scaffolds. Porosity of cell-free collagen sponge was 86%, and decreased to 73% and 56% after 7 days and 3 weeks of culturing, respectively. When microCT images of horizontal cross section of the unseeded and cell seeded sponges were investigated, the exterior of the collagen sponge where cells proliferated and formed cell clusters 19 appeared brighter than the core of the sponges (Figure 5H ). X-ray absorption of the unseeded sample (examined along the red line) is almost linear demonstrating the homogenous composition of the collagen sponge (Figure 5H, right) . The red lines show the direction in which the spectra were taken.
Properties of the Complete Bone Tumor Model (BTM)
Microscopy Results
The complete bone tumor model (BTM) has two compartments and is formed by combination of tumor mimic and healthy bone mimic. Experiments carried out on individual sponges (PLGA and collagen) were also performed with the BTM. Cell nuclei and cytoskeleton were stained and since the dyes stained the cells indiscriminately, the cells could not be distinguished from each other ( Figure 6A-D) . Cells on the BTM attached, spread and covered the surfaces of the scaffolds by Day 21. In Figure 6E -H, samples were stained with anti-von Willebrand factor (vWF) (red) and CD31 antibody (pink) dyes, both of which are specific for HUVECs. Cytoskeleton (green) and nucleus (blue) of the cells were also stained. Due to the specificity of these dyes, it became possible to distinguish HUVECs from the other two cell types, and they were detected on the exterior and the top surface of the collagen sponge (Figure 6E, F) in addition to exterior and bottom surfaces of the PLGA/TCP scaffold (Figure 6G, H) . Since HUVECs and hFOB were seeded only on the PLGA/TCP scaffolds, the presence of HUVECs on the PLGA/TCP scaffold was expected, but their detection on the collagen sponge demonstrates that these cells have (Figure 6M, N) were stained to show the migration of HUVECs to the core of the cancer mimic (collagen). Cells of the healthy bone mimic were mainly detected in the regions that are in direct contact with the collagen core, the cancer mimic. HUVECs (pink) that have migrated into the tumor area are clearly seen in Figure 6N (magnified image of Figure 6M ). The direct contact between the scaffolds apparently allowed the migration of the endothelial cells to the tumor side as if to vascularize the tumor. This is a good indicator that the model works. The microCT of the horizontal section of BTM also showed this direct contact between the two regions indicating that this model has a good potential to mimic the cancer tissue (Figure 6O) . 
Molecular Analysis of Angiogenesis
Expression of angiogenic factors (VEGF, bFGF, and IL-8) in the BTM was studied with realtime quantitative PCR (RT-PCR) for 21 days (Figure 7) . In this analysis, three types of samples were used: Saos-2 cells cultured on: 1) TCPS (control group), 2) collagen sponge, and 3) collagen sponge in BTM.
At certain time points, the collagen sponges were treated for RNA isolation and qRT-PCR analysis. In case of BMT model, the collagen sponges were separated from PLGA/TCP scaffolds.
Relative VEGF and bFGF gene expression levels are presented in Figure 7A the expression level of VEGF, and that of tumor progression as was observed in our study. (45, 46) VEGF is a powerful angiogenic factor, and it is generally believed that tumor cells secrete VEGF to enhance the formation of its own vascular network. (47) It stimulates the formation of new blood vessels and controls apoptosis and differentiation of tumor cells and osteoblasts. It has an effect on tumor progression and pathological remodeling. However, the VEGF expression level in the later days decreased probably as a result of a negative feedback mechanism. As reported in some studies, (48) (49) (50) there are some negative regulators that influence angiogenesis in an autocrine manner leading to downregulation of VEGF. Some of these regulators are directly induced by stimulators of angiogenesis, especially VEGF, as a consequence of a specific negative-feedback regulator mechanism of angiogenesis. (51) There was also no significant difference in bFGF expression by Saos-2 cells in the collagen sponge alone, but in case of BTM these values were higher by approximately 10, 110 and 300 times on Days 7, 14 and 21, respectively. These high levels and the substantial increase are probably a synergic effect of the interactions and cross-talk between the hFOB and HUVECs seeded into the model. As a result, we showed that the expression of proangiogenic factors increased significantly in the two compartment novel bone tumor model, indicating the success of mimicking the natural tissue.
Study of Efficacy of the Anticancer Agent on Cell Viability on BTM
In order to assess the suitability of the constructed BTM to serve as a cancer tissue model, Doxorubicin (a drug used in osteosarcoma therapy) was added into the system and its effectiveness on viability of the cells was studied. Initially, a dose-response curve was prepared in vitro with Saos-2 cells in the tissue culture plate and exposed to a range of concentrations of the drug. Dose-Response curve (Figure S2) showed that the IC50 value of Doxorubicin was 0.1876 µg.mL -1 when the seeding density was 2x10 4 cells per well. Since almost the cells on the BTM was 15 fold higher than on the TCPS wells (3x10 5 cells), 15 fold higher drug concentration (2.7 µg.mL -1 Doxorubicin) was used on the model. Alamar Blue cell viability test showed that the cell number was significantly decreased following treatment with Doxorubicin (Figure 8A) . Figure 8B shows the activity (thus the amount) of the caspase-3 enzyme in the Doxorubicin-administered BTM. Doxorubicin was applied to the bicomponent bone tumor model, and then the two cell-seeded sponges (exterior PLGA and core collagen) were separated from each other for the analysis of the enzymatic activity on each component. A significant increase in caspase-3 activity was determined in the collagen sponge, while there was no significant change in healthy bone tissue mimic. It was expected that the drug would be more effective on cancer tissue mimic because of the cancer cells loaded in it. Live/Dead assay also showed lower viability in the Doxorubicin-treated model than the untreated one (Figure 8C) . Doxorubicin was more effective at the top surface of the collagen sponge possibly because this part of the model was in more direct contact with the drug containing culture medium because it is exposed to it (Figure 8C, top row) . A drug dose killing all the cells in the tissue culture plates but only a portion in the BTM is also a good indicator of the difference in the effect of the drugs on 2D and 3D cultures. Apparently, the cells in the culture plate (the 2D environment) are more exposed to the culture conditions while in the 3D BTM model the microenvironment prevents such direct effects. In Figure 8C , the collagen sponge bottom surface and the PLGA/TCP sponge cavity bottom surface are not in direct contact with 25 the drug-containing medium and so the number of affected cells is lower than those at the top surface of the collagen sponge. It can, therefore, be concluded that the BTM developed in this study mimics the bone tumor; of course, further experiments are needed to optimize the parameters before initiating any patient specific human trials. Student's T-test was used, n=3, results were significant, B: one-way ANOVA followed by Tukey post-hoc test, result were significant ***p < 0.001, and ns: not significant, n=3).
Caspase-3 enzyme activity is an indicator of apoptosis and
26
The results presented in the study showed that the bone tumor model could mimic the natural osteosarcoma and would be considered for studying the efficacy of different types of drugs on cells obtained from a patient for a 'patient specific treatment'. However, several optimization steps should be performed. Although proliferation of Saos-2 cells and their interactions with HUVECs were observed, formation of spheroids was not. In the literature, there are studies carried out with spheroids. It is known that tumor cells in spheroids have strong cell-cell interactions and a different morphology than cells in a 2D monolayer culture. Interactions between cells in 3D spheroids also increase their stability and survival rates showing resistance to anti-cancer agents. (54) (55) (56) Thus, studies with spheroids need to be performed and the core collagen should carry these instead of individual cells. Studies along this line are in progress."
Conclusion
In this study, a functional 3D bone tumor model (BTM) was successfully developed by combining two components: 1) a tumor mimic consisting of osteosarcoma (Saos-2) cells seeded in a collagen sponge, and 2) healthy bone mimic that was formed by seeding hFOB and HUVECs in PLGA/TCP sponge. This model aimed to mimick the in vivo tumor stroma by providing not only the cross-talk between the cancer cells, but also the interactions of cancer cells with the healthy bone cells and the bone matrix. The natural bone tumor microenvironment constructed in this manner led to cancer cells increasing their expression of angiogenic factors when cultured in the BTM model. A direct contact between the healthy bone cells (hFOB and HUVECs) and cancer cells (Saos-2) was achieved, and when treated with the anticancer agent, Doxorubicin, the effect was observed specifically on the cancer cells. These indicate that this new strategy in tumor modeling, with tumor cells cultured within an engineered bone construct, could create a microenvironment similar to that of the native tissue. In conclusion, we believe the 3D BTM developed in this study could be a good candidate for screening tests of drug efficacy. This will also be a promising approach in the personalized drug therapy in finding the right type, combination and dose regimens of the drugs for a specific individual.
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